Skip to Main Content
Pharmacist's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • New Drugs
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Guide to Cannabis training for pharmacists that offers 16 hours of ACPE-accredited training based on the latest, science-based cannabis research. Only $199. Learn More!
  1. Home
  2. Browse
  3. Cardiology
  4. Ischemic Heart Disease/Acute Coronary Syndromes
  5. Treatment
  6. Prasugrel (Effient)

Prasugrel (Effient)

  • Angina (14)
  • Antithrombotics (367)
  • Arrhythmias (177)
  • Blood Pressure (30)
  • Cardiovascular Disease and Depression (9)
  • Cholesterol (57)
  • Dyslipidemia (270)
  • Endocarditis (20)
  • Heart Disease (78)
  • Heart Failure (183)
  • Hypertension (303)
  • Hypotension (19)
  • Ischemic Heart Disease/Acute Coronary Syndromes (354)
    • Cardiovascular Markers (26)
    • Drug-Induced Ischemic Heart Disease (39)
    • Guidelines (4)
    • Prevention (68)
    • Treatment (274)
      • ACEIs (67)
      • Anticoagulants (32)
      • ARBs (62)
      • ARNIs (8)
      • Aspirin (83)
      • Beta-Blockers (78)
      • Calcium Channel Blockers (26)
      • Clopidogrel (Plavix) (49)
      • Natural Medicines/Supplements (8)
      • Nitrates (13)
      • Prasugrel (Effient) (25)
      • Statins (45)
  • Myocardial Infarction (42)
  • Peripheral Vascular Disease (9)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (1)
  • Resources (901)
  • Stroke (170)
1 - 15 of 25 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Individualize Duration of Dual Antiplatelet Therapy in Stent Patients February 2022
Chart: Cytochrome P450 (CYP) Drug Interactions June 2020
Chart: Comparison of Oral Anticoagulants December 2019
FAQ: Combination Antithrombotic Therapy: FAQs May 2019
Article: Expect Some Stent Patients to Be Switched to Clopidogrel November 2017
Chart: Comparison of Oral Antiplatelets November 2017
Commentary: Proton Pump Inhibitor and Plavix Interaction: An Update June 2013
Article: Brilinta (ticagrelor) for acute coronary syndrome May 2012
PL Voices: Which Antiplatelet Drug to Add to Aspirin for Acute Coronary Syndrome May 2012
Commentary: Antiplatelets After Acute Coronary Syndrome or Coronary Stent May 2012
Article: the risk of stopping aspirin, clopidogrel, or other antiplatelet drugs too soon September 2011
PL Voices: Discontinuing Antiplatelet Agents September 2011
Commentary: Discontinuing Antiplatelet Agents September 2011
Article: Brilinta (ticagrelor) will compete with Plavix and Effient July 2011
Commentary: New Drug: Brilinta (Ticagrelor) July 2011
  • 1
  • 2
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved